152 related articles for article (PubMed ID: 7030907)
21. Hepatic expression of hepatitis B and delta virus antigens in patients with acute and chronic hepatitis.
Pilleri G; Faa G; Liguori C; Goffi C; Lai E
Ric Clin Lab; 1985; 15(4):337-42. PubMed ID: 3914698
[TBL] [Abstract][Full Text] [Related]
22. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
23. Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients.
Ray MB; Desmet VJ; Bradburne AF; Desmyter J; Fevery J; De Groote J
Gastroenterology; 1976 Sep; 71(3):462-9. PubMed ID: 59675
[TBL] [Abstract][Full Text] [Related]
24. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy.
Lin CY; Lin CC; Chang GJ; King CC
Nephron; 1997; 76(2):176-85. PubMed ID: 9200409
[TBL] [Abstract][Full Text] [Related]
25. Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies.
Mondelli M; Tedder RS; Ferns B; Pontisso P; Realdi G; Alberti A
Hepatology; 1986; 6(2):199-204. PubMed ID: 3514406
[TBL] [Abstract][Full Text] [Related]
26. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers.
Hadziyannis SJ; Sherman M; Lieberman HM; Shafritz DA
Hepatology; 1985; 5(4):544-7. PubMed ID: 4018727
[TBL] [Abstract][Full Text] [Related]
27. [Delta infection in HBsAg carriers].
Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
[TBL] [Abstract][Full Text] [Related]
28. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
29. Fulminant delta hepatitis in chronic hepatitis B infection.
De Cock KM; Govindarajan S; Redeker AG
JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
[TBL] [Abstract][Full Text] [Related]
30. Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen.
Sällberg M; Hughes J; Javadian A; Ronlov G; Hultgren C; Townsend K; Anderson CG; O'Dea J; Alfonso J; Eason R; Murthy KK; Jolly DJ; Chang SM; Mento SJ; Milich D; Lee WT
Hum Gene Ther; 1998 Aug; 9(12):1719-29. PubMed ID: 9721082
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection.
Smedile A; Lavarini C; Crivelli O; Raimondo G; Fassone M; Rizzetto M
J Med Virol; 1982; 9(2):131-8. PubMed ID: 6175733
[TBL] [Abstract][Full Text] [Related]
32. Anti-DNA, anti-HBc correlations with RIA-detected HBeAg and anti-HBe in chronic HBsAg carriers.
Villarejos VM; Andersen-Visoná K; Serra J; Frösner GG; Deinhardt F
J Med Virol; 1980; 5(4):265-71. PubMed ID: 7229619
[TBL] [Abstract][Full Text] [Related]
33. Is there a hepatitis B virus-associated glomerulonephritis? Identification of HBsAG, HBcAG and HBeAG in kidney with monoclonal antibodies.
Zhang JH; Li LS; Zhou H
Chin Med J (Engl); 1989 Jul; 102(7):496-504. PubMed ID: 2517065
[TBL] [Abstract][Full Text] [Related]
34. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
Rizzetto M; Shih JW; Gocke DJ; Purcell RH; Verme G; Gerin JL
Lancet; 1979 Nov; 2(8150):986-90. PubMed ID: 91776
[TBL] [Abstract][Full Text] [Related]
35. The IgM antibody responses to the core antigen of hepatitis B virus.
Cohen BJ
J Med Virol; 1978; 3(2):141-9. PubMed ID: 731226
[TBL] [Abstract][Full Text] [Related]
36. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
[TBL] [Abstract][Full Text] [Related]
37. Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen.
Ramalho F; Brunetto MR; Rocca G; Piccari GG; Batista A; Chiaberge E; Lavarini C; Dal Monte RP; Carneiro de Moura M; Bonino F
J Hepatol; 1988 Aug; 7(1):14-20. PubMed ID: 3183349
[TBL] [Abstract][Full Text] [Related]
38. Correlation between hepatic hepatitis B core antigen and serum hepatitis B virus-DNA levels in patients with chronic hepatitis B virus infections in Taiwan.
Wu JC; Lee SD; Wang JY; Ting LP; Tsai YT; Tsay SH; Tong MJ
Arch Pathol Lab Med; 1987 Feb; 111(2):181-4. PubMed ID: 3545139
[TBL] [Abstract][Full Text] [Related]
39. Relationship between intrahepatic expression of hepatitis B viral antigens and histology in Chinese patients with chronic hepatitis B virus infection.
Wu PC; Lau JY; Lau TK; Lau SK; Lai CL
Am J Clin Pathol; 1993 Dec; 100(6):648-53. PubMed ID: 8249912
[TBL] [Abstract][Full Text] [Related]
40. e System and intrahepatocelullar HBcAG and HBsAG in HBsAG positive patients with liver diseases and healthy carriers.
Hess G; Nielsen JO; Arnold W; Büschenfelde KH
Scand J Gastroenterol; 1977; 12(3):325-30. PubMed ID: 866995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
